{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:03:06Z","timestamp":1759104186706,"version":"3.44.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1016\/j.jneuroim.2005.02.014","type":"journal-article","created":{"date-parts":[[2005,4,13]],"date-time":"2005-04-13T13:01:38Z","timestamp":1113397298000},"page":"195-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Lymphocyte subsets, TNF\u03b1 and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients"],"prefix":"10.1016","volume":"163","author":[{"given":"Banu","family":"Anlar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev","family":"Guven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulsen","family":"K\u00f6se","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamza","family":"Okur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozg\u00fc","family":"Kose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omer F.","family":"Aydin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nimet","family":"Kabakus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakir","family":"Altunbasak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ozlem","family":"Herguner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mujgan","family":"Sonmez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayse","family":"Serdaroglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2005.02.014_bib1","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000117007","article-title":"The effect of inosiplex in subacute sclerosing panencephalitis: a clinical and laboratory study","volume":"34","author":"Anlar","year":"1994","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/088307380101601206","article-title":"Tissue inflammatory response in subacute sclerosing panencephalitis (SSPE)","volume":"16","author":"Anlar","year":"2001","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0387-7604(84)80114-X","article-title":"Cell mediated immunity in patients with subacute sclerosing panencephalitis","volume":"6","author":"Aysun","year":"1984","journal-title":"Brain Develop."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0165-5728(97)00146-X","article-title":"Alpha interferon treatment in myasthenia gravis: effects on natural killer cell activity","volume":"82","author":"Bolay","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/WNL.36.7.992","article-title":"Subacute sclerosing panencephalitis and progressive multiple sclerosis: T cell subsets in blood and CSF","volume":"36","author":"Czlonkowska","year":"1986","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2005.02.014_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1128\/iai.33.1.34-42.1981","article-title":"Cellular and humoral immunity in subacute sclerosing panencephalitis","volume":"33","author":"Dhib-Jalbut","year":"1981","journal-title":"Infect. Immun."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib7","doi-asserted-by":"crossref","first-page":"5469","DOI":"10.1128\/jvi.69.9.5469-5474.1995","article-title":"Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis","volume":"69","author":"Finke","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib9","first-page":"939","article-title":"Changes in lymphocyte subsets and treatment with beta interferon in active multiple sclerosis","volume":"27","author":"Gata","year":"1988","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1177\/088307380101600606","article-title":"Interleukin-1beta, interleukin-1 receptor antagonist levels in patients with subacute sclerosing panencephalitis and the effects of different treatment protocols","volume":"16","author":"Haspolat","year":"2001","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib12","first-page":"125","article-title":"Peripheral blood lymphocyte subsets in healthy Turkish children","volume":"46","author":"Ikinciogullari","year":"2004","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib14","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/archneur.59.5.822","article-title":"Contribution of the interleukin 4 gene to susceptibility to subacute sclerosing panencephalitis","volume":"59","author":"Inoue","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib15","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0165-5728(99)00184-8","article-title":"Reduction of both pro- and anti-inflammatory cytokines after 6 months of interferon beta-1a treatment of multiple sclerosis","volume":"103","author":"Khademi","year":"2000","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/jnnp.49.6.713","article-title":"Lymphocyte subsets at different stages of subacute sclerosing panencephalitis: a study with monoclonal antibodies","volume":"49","author":"Marrosu","year":"1986","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2005.02.014_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0165-5728(98)00154-4","article-title":"Immunomodulatory effects of interferon-beta-1b in vivo: induction of the expression of transforming growth factor-beta1 and its receptor type II","volume":"91","author":"Ossege","year":"1998","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib19","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S1567-5769(01)00039-X","article-title":"Immunomodulatory effects of interferon-beta-1b in patients with multiple sclerosis","volume":"1","author":"Ossege","year":"2001","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib21","first-page":"23","article-title":"Subpopulations of T lymphocytes in subacute sclerosing panencephalitis (SSPE)","volume":"28","author":"Sanal","year":"1986","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib22","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1177\/088307389901400702","article-title":"Lymphocyte subsets and inflammatory mediators in patients with subacute sclerosing panencephalitis","volume":"14","author":"Tekgul","year":"1999","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.jneuroim.2005.02.014_bib23","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1212\/WNL.42.3.488","article-title":"Intraventricular interferon and oral inosiplex in the treatment of subacute sclerosing panencephalitis","volume":"42","author":"Yalaz","year":"1992","journal-title":"Neurology"}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280500086X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016557280500086X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:01:35Z","timestamp":1759046495000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016557280500086X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":18,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2005,6]]}},"alternative-id":["S016557280500086X"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.02.014","relation":{},"ISSN":["0165-5728"],"issn-type":[{"type":"print","value":"0165-5728"}],"subject":[],"published":{"date-parts":[[2005,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lymphocyte subsets, TNF\u03b1 and interleukin-4 levels in treated and untreated subacute sclerosing panencephalitis patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2005.02.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}